Post-IPO Equity - Kala Pharmaceuticals - Apr 6, 2020 Funding Round Profile - Cointime

Bitcoin $93,666.15 -1.06%
Ethereum $3,361.09 -0.66%
BNB $700.34 -3.37%
Optimism $1.82 -2.53%
Arbitrum $0.75 -1.83%
Solana $193.02 -0.19%
Polygon $0.47 -2.85%
Cosmos $6.35 -2.89%
Avalanche $36.27 -3.15%

Bitcoin $93,666.15 -1.06%
Ethereum $3,361.09 -0.66%
BNB $700.34 -3.37%
Optimism $1.82 -2.53%
Arbitrum $0.75 -1.83%
Solana $193.02 -0.19%
Polygon $0.47 -2.85%
Cosmos $6.35 -2.89%
Avalanche $36.27 -3.15%

Kala Pharmaceuticals

company

Funding Round

Post-IPO Equity

Money Raised

$ 134M

Propotion

-

Post Valuation

-

Current Round Investors

Investor Name	Invest Money	Lead Investor	Propotion

Historical Financing

Announced Date	Round	Money Raised	Investors
Oct 3, 2018	Post-IPO Equity	$ 110M	Athyrium Capital Management LP	Detail
Apr 13, 2016	Series C	$ 68M	CAM Capital,Longitude Capital,etc.	Detail
Feb 28, 2013	Series A	$ 11.50M	Crown Venture Fund,Lux Capital,etc.	Detail
Apr 23, 2014	Series B	$ 22.50M	AbbVie Biotech Ventures,Crown Venture Fund,etc.	Detail
Dec 24, 2009	Series A	$ 2M		Detail
Mar 14, 2012	Private Equity（PE）	$ 7.24M	Lighthouse Capital Partners,Lux Capital,etc.	Detail
Nov 10, 2010	Series Unknown	$ 3M		Detail
Aug 17, 2015	Series Unknown	$ 6.99M		Detail
Jul 20, 2017	IPO	$ 90M		Detail